Literature DB >> 30840949

A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan.

Yasuhisa Sakata1, Nanae Tsuruoka2, Hironobu Takedomi2, Takashi Akutagawa2, Ryo Shimoda2, Motohiro Esaki2, Kazuma Fujimoto2.   

Abstract

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) are widely used for the management of acid-related diseases. This study aimed to clarify the status of PPI use in hospitalized patients.
METHOD: A retrospective observational study was performed. We analyzed PPI prescription data for the past 8 years (2009-2016) using Diagnosis Procedure Combination survey data from approximately 10,000 patients per year at Saga University Hospital. We investigated the trend in the number of hospitalized patients who were prescribed PPI for the past 8 years and the changes in patient characteristics.
RESULTS: We identified 11,009 patients using PPIs throughout the study period. PPI prescription proportions significantly increased over the study period. The use of PPIs increased steadily with increasing age. The proportion of PPIs prescribed was 1.3-times higher among men than compared with women. In most clinical departments, the number of patients prescribed PPIs was up to 3 times higher in the second half of the period (2013-2016) compared with the first half of the period (2009-2012). The number of patients taking concomitant PPIs and anticoagulants or dual antithrombotic combination therapy increased.
CONCLUSION: PPI use has increased substantially in hospitalized patients. The prevalence of PPI prescription by doctors other than gastroenterologists also increased.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Antithrombotic agent; Nonsteroidal anti-inflammatory drugs; Potassium-competitive acid blocker; Proton pump inhibitor

Year:  2019        PMID: 30840949     DOI: 10.1159/000498967

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  3 in total

1.  Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.

Authors:  Yuta Yokoya; Ataru Igarashi; Akihito Uda; Hisato Deguchi; Toshihisa Takeuchi; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2019-08-08       Impact factor: 7.527

2.  Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan.

Authors:  Nobutake Yamamichi; Takeshi Shimamoto; Yu Takahashi; Mami Takahashi; Chihiro Takeuchi; Ryoichi Wada; Mitsuhiro Fujishiro
Journal:  PLoS One       Date:  2022-06-17       Impact factor: 3.752

3.  Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010-2018.

Authors:  Ute Amann; Sebastian-Edgar Baumeister; Ina-Maria Rückert-Eheberg; Michael Nolde; Nayeon Ahn; Martin Tauscher; Roman Gerlach; Florian Güntner; Alexander Günter; Christa Meisinger; Jakob Linseisen
Journal:  Eur J Clin Pharmacol       Date:  2021-12-08       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.